Abstract
This paper is based on a presentation made by the author at the meeting of the American Urological Association’s Society for the Study of Impotence on April 12, 1997. The author addresses the general applicability of the Federal Trade Commission Act to advertising by so-called impotence ‘treatment mills,’ focusing in particular on the Federal Trade Commission’s case in the matter of Genetus Alexandria, Inc., et al.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mills, S. ‘Treatment mills’ under the Federal Trade Commission Act. Int J Impot Res 10, 105–109 (1998). https://doi.org/10.1038/sj.ijir.3900327
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3900327